A number of tau-based therapeutic approaches for AD are being explored directed at stabilizing microtubules, physically blocking tau aggregation, inhibiting protein kinases involved in tau hyperphosphorylation, and removing extracellular tau immunologically. This evidence concerns the gene MAPT and Alzheimer disease.